Vera Therapeutics VERA Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Vera Therapeutics's accrued liabilities, current?
- Vera Therapeutics (VERA) reported accrued liabilities, current of $31.24M in Q1 2026.
- How has Vera Therapeutics's accrued liabilities, current changed year-over-year?
- Vera Therapeutics's accrued liabilities, current increased by 173.1% year-over-year, from $11.44M to $31.24M.
- What is the long-term trend for Vera Therapeutics's accrued liabilities, current?
- Over 5 years (2020 to 2025), Vera Therapeutics's accrued liabilities, current has grown at a 126.0% compound annual growth rate (CAGR), from $535K to $31.56M.